Board MeetingMay 6, 2026, 08:32 AM
Allogene Therapeutics Q1 2026 Earnings Call Scheduled for May 13
AI Summary
Allogene Therapeutics, Inc. announced it will report its first quarter 2026 financial results and provide a business update on May 13, 2026, after the close of the market. This will be followed by a live audio webcast and conference call at 2 p.m. PT/5 p.m. ET. A listen-only webcast will be available on the company's website, with registration required for those wishing to ask questions.
Key Highlights
- Allogene Therapeutics to report first quarter 2026 financial results and provide a business update on May 13, 2026.
- A live audio webcast and conference call will follow the announcement at 2 p.m. PT/5 p.m. ET.
- The listen-only webcast will be available on the company's website under the Investors tab.
- Participants wishing to ask questions on the conference call must register to receive a personal PIN.
Price Impact
More from ALLO